Berthon, Céline <br/><br/>
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study.  [electronic resource] 

 -  The Lancet. Haematology  Apr 2016 
 - e186-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2352-3026 
<br/><br/><label>Standard No.: </label>10.1016/S2352-3026(15)00247-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--administration & dosage<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Canada<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>France<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Treatment Outcome<br/>United Kingdom